Assembly Biosciences (ASMB) EBITDA Margin (2017 - 2026)
Assembly Biosciences (ASMB) reported EBITDA Margin of -47.29% for Q2 2026, up 67.62 percentage points from -114.91% a year earlier and up 90.84 percentage points from the prior quarter.
Powered by 
Analysis
Assembly Biosciences (ASMB) EBITDA Margin (2017 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Assembly Biosciences' EBITDA Margin came in at -11.61%, up 118.91 percentage points year-over-year; for FY2025, it was -16.58%, up 142.22 percentage points from FY2024.
- EBITDA Margin has a five-year change of +64.43 percentage points (FY2020 to FY2025).
- By year, EBITDA Margin came in at -158.80% in FY2024 (+737.41 pp), -896.22% in FY2023 and -2114.20% in FY2021 (-2033.19 pp).
- Five-year quarterly EBITDA Margin spans a low of -299.90% in Q3 2021 and a high of 46.70% in Q4 2025.
- Year over year, EBITDA Margin gained in six of the last seven quarters, with an average year-over-year change of +60.27 percentage points.
- The high point for year-over-year EBITDA Margin in five years was Q4 2025 (a gain of 203.01 percentage points); the low point was Q3 2021 (a drop of 288.70 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -138.12% (Q1 2026), 46.70% (Q4 2025) and -100.57% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Assembly Biosciences | 468.67 Mn | -558.96 Mn | - | -47.29% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -47.29% |
| Mar 31, 2026 | -138.12% |
| Dec 31, 2025 | 46.70% |
| Sep 30, 2025 | -100.57% |
| Jun 30, 2025 | -114.91% |
| Mar 31, 2025 | -105.19% |
| Dec 31, 2024 | -156.31% |
| Sep 30, 2024 | -159.58% |
| Jun 30, 2024 | -142.63% |
| Mar 31, 2024 | -184.91% |
| Dec 31, 2023 | -174.05% |
| Sep 30, 2021 | -299.90% |
| Dec 31, 2020 | -3,792.48% |
| Sep 30, 2020 | -11.21% |
| Jun 30, 2020 | 17.02% |
| Mar 31, 2020 | -675.79% |
| Dec 31, 2019 | -599.27% |
| Sep 30, 2019 | -611.58% |
| Jun 30, 2019 | -635.55% |
| Mar 31, 2019 | -725.89% |
API Access
Assembly Biosciences EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ASMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ASMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ASMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();